The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human ...
Artisan Partners' David Samra is publicly calling for Novartis to overhaul its board and compensation structure following ...
Governance pressure is intensifying at Novartis, with calls to penalize dealmakers for failed M&A and align executive pay ...
A patient checks in and sits down, closer to their own health than they will be at almost any other point in the year, turning over the questions they mean to ask, the decision they're about to make.
For more than 20 years now, companies in the life sciences industry have waved the banner of patient-centricity, spending on advisory boards, listening sessions and even “patient weeks” in their ...
Dr. Elena Christofides on why the overnight dexamethasone suppression test is the only cortisol screen that actually identifies HPA dysfunction. GLP-1 medications might be most well-known as ...
Learn how ClaimGuardRx addresses both diversion and fraud through a single, conversational platform. Understand why the voice ...
An oversubscribed $70 million Series B, co-led by Alpha Wave and YK Bioventures with Eli Lilly participation, funds clinical ...
Caspian Therapeutics was launched with $50 million to progress KO-7246 through IND-enabling development and early clinical evaluation in patients with diabetes. Menin inhibition is positioned as ...
Our survey findings highlight the critical need for reforms to ensure that IBD patients can access the medications they need ...
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 ...
Sebastian Arana, head of process solutions at MilliporeSigma, discusses the operational tradeoffs facilities face as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results